Lysiane Molina Selected Research

Lysiane Molina Research Topics

3	Pathologic Complete Response 02/2024 - 05/2005
3	Lymphoma (Lymphomas) 01/2023 - 01/2019
2	Hodgkin Disease (Hodgkin's Disease) 10/2023 - 04/2021
1	Hairy Cell Leukemia 02/2024
1	Lymphadenopathy 01/2023
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023
1	Hyperplasia 01/2023
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Plasmablastic Lymphoma 01/2015
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2005

3	obinutuzumabIBA 01/2023 - 01/2019
3	Lenalidomide (CC 5013)FDA Link 01/2022 - 01/2015
2	Dacarbazine (DIC)FDA LinkGeneric 10/2023 - 04/2021
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2023 - 04/2021
2	Brentuximab VedotinIBA 10/2023 - 04/2021
2	Vinblastine (Vinblastine Sulfate)FDA Link 10/2023 - 04/2021
1	Rituximab (Mabthera)FDA Link 02/2024
1	Cladribine FDA LinkGeneric 02/2024
1	fludarabineIBA 01/2023
1	ibrutinibIBA 01/2023
1	Dasatinib (BMS 354825)FDA Link 01/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023
1	Daunorubicin (Cerubidine)FDA LinkGeneric 05/2005
1	Cytarabine (Cytosar-U)FDA LinkGeneric 05/2005